title: Use of intracavernosal alprostadil in erectile dysfunction.
abstract: Alprostadil (prostaglandin E1) is the most widely used, licensed vasoactive agent for intracorporeal injection in the investigation and treatment of erectile dysfunction. It has a good side-effect profile and is effective in between 70 and 80% of patients.
authors.affiliation: Bristol Urological Institute, Southmead Hospital.
authors.forename: C
authors.initials: C
authors.lastname: Gingell
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D000527:Alprostadil